Government, drug industry lean on trade talks to ease Trump’s drug tariff plan | Today’s news

“Shifting the entire generic manufacturing ecosystem from India to the US remains a distant prospect,” said Namit Joshi, chairman of the Pharmaceutical Export Promotion Council of India (Pharmexcil), adding that most new investment in the US is focused on branded and patented drugs, not generics, where commercial returns are much lower.